R01 CA248205/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2024	1
2025	1

Page 1

Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.

Ghosh S, Mazumdar T, Xu W, Powell RT, Stephan C, Shen L, Shah PA, Pickering CR, Myers JN, Wang J, Frederick MJ, Johnson FM. Ghosh S, et al. Clin Cancer Res. 2022 Oct 14;28(20):4479-4493. doi: 10.1158/1078-0432.CCR-22-1627. Clin Cancer Res. 2022. PMID: 35972731 Free PMC article.

Phase 1/2 Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas.

Johnson FM, O'Hara MP, Yapindi L, Jiang P, Tran HT, Reuben A, Xiao W, Gillison M, Sun X, Khalaf A, Lee JJ, Sastry JK, Ghosh S. Johnson FM, et al. Clin Cancer Res. 2024 Nov 26. doi: 10.1158/1078-0432.CCR-24-2290. Online ahead of print. Clin Cancer Res. 2024. PMID: 39589337

Targeted inhibition of Aurora kinase A promotes immune checkpoint inhibition efficacy in human papillomavirus-driven cancers.

Ghosh S, O'Hara MP, Sinha P, Mazumdar T, Yapindi L, Sastry JK, Johnson FM. Ghosh S, et al. J Immunother Cancer. 2025 Jan 7;13(1):e009316. doi: 10.1136/jitc-2024-009316. J Immunother Cancer. 2025. PMID: 39773561 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year